Home › Celgene's Pending Sanctions Motions against Kyle Bass's Hedge Fund
 

Keywords :   


Celgene's Pending Sanctions Motions against Kyle Bass's Hedge Fund

2015-08-27 05:51:32| Biotech - Topix.net

The Patent Trial and Appeals Board previously authorized Celgene Corporation to move for sanctions against the Coalition for Affordable Drugs , an entity affiliated with a Kyle Bass hedge fund that had filed several inter partes review petitions against Celgene and other biotech companies. As expected, Celgene's recently filed motion focuses on the Coalition's underlying goal of "profit[ing] by affecting stock prices."

Tags: fund pending kyle sanctions

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Atlantic Tropical Weather Outlook
03.07Hurricane Beryl Public Advisory Number 17A
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Eastern North Pacific Tropical Weather Outlook
03.07How Microsoft and Nvidia bet correctly to leapfrog Apple
03.07Acreage and stocks estimates push corn prices lower
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
More »